AGMB AgomAb Therapeutics NV

NEUTRAL Impact: 2/10 PRESS-RELEASE
Horizon immediate Filed May 14, 2026 Processed 1mo ago Wire GlobeNewswire
Press release: announcement
Latest settled — T+5d
AGMB ▼ -0.91% at T+5d
NEUTRAL call ✗ call lost -0.91% · α vs SPY -0.19% · entry $11.04 → $10.94
Next anchor: T+20d due 3d ago
Last close $9.61 (close Jun 12) · -12.95% from $11.04 entry
Entry anchored
May 14, 2026
via day open
T+1d
-4.44%
call -4.44% · α -3.21%
$10.55
settled 4w ago
T+5d
-0.91%
call -0.91% · α -0.19%
$10.94
settled 25d ago
T+20d
call — · α —
due 3d ago
T+60d
call — · α —
in 8w

Price Chart

Loading chart...

Executive Summary

Agomab Therapeutics announced that management will participate in upcoming industry and investor conferences. This is a routine non-financial announcement with no material impact on the company's operations or valuation.

Actionable Insight

Monitor for any material announcements or data presentations that may occur during the conferences. No immediate trading action warranted.

Key Facts

  • Management participation in upcoming conferences is a standard business development activity

Financial Impact

No financial impact from this announcement

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
90% bullish (10 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3294788
4 reports for AGMB
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for AGMB — sortable, filterable
Type Now
May 27, 2026
18d ago
Press Release
NEUTRAL ★ 2/10
$11.67 $12.00▲ +2.83%▲ +2.36%$9.61 (−17.65%)
May 14, 2026
4w ago
Press Release
NEUTRAL ★ 2/10
$11.04 $10.94▼ −0.91%▼ −0.19%$9.61 (−12.95%)
Apr 24, 2026
7w ago
6-K
BULLISH ★ 8/10
$11.32 $12.11▲ +6.98%▲ +6.58%$9.61 (−15.11%)
Mar 26, 2026
11w ago
Press Release
NEUTRAL ★ 5/10
$11.87 $10.72▼ −9.69%▼ −11.32%$9.61 (−19.04%)
Showing 4 of 4

US Market Status

Market Closed — Opens in 5h 5m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access